ProjectKlinische Studie
Basic data
Title:
Klinische Studie
Duration:
12/04/2017 to 30/11/2021
Abstract / short description:
"A multicenter, open Label, study to assess the sefety and efficacy of Risankizumab for maintenance in moderate to severe plaque psoriasis (LIMMITLESS)"
Folgestudie der BI 1311.3
Folgestudie der BI 1311.3
Keywords:
psoriasis
Schuppenflechte
psoriasis therapeutics
Psoriasis Therapeutika
clinical trial
klinische Studie
dermatology
Dermatologie
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Wiesbaden, Hessen, Germany